echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Experts commented that Cell Stem Cell Xie Cen / He Shijun and others collaborated to discover a new evidence of "liver treatment of intestinal diseases" - the liver bile acid metabolism axis regulates the repair of intestinal epithelial damage

    Experts commented that Cell Stem Cell Xie Cen / He Shijun and others collaborated to discover a new evidence of "liver treatment of intestinal diseases" - the liver bile acid metabolism axis regulates the repair of intestinal epithelial damage

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Reviews | Liejun Guo (Rutgers University), Wei Jia (Hong Kong Baptist University, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University)


    Editor-in-charge |





    Leucine-rich repetitive G protein-coupled receptor 5 (Lgr5) is a surface marker of ISCs, which are mainly distributed at the base of the crypt and maintain the normal function



    Finally, the researchers applied the FXR agonist Obecholic acid (there is currently no CYP8B1-specific inhibitor) to inhibit CYP8B1 expression, and found that it could restore Lgr5+ ISCs activity and effectively improve enteritis, further demonstrating the important role of



    In summary, the study elucidated the new mechanism of liver bile acid metabolism enzyme CYP8B1 and its product CA involved in the progression of intestinal inflammation, identified the metabolic signaling molecule CA for cross-organ communication, and proposed a new idea




    https://doi.



    Model Maker: Eleven

    References


    2.


    3.
    Mousa, O.
    Y.
    , Juran, B.
    D.
    , McCauley, B.
    M.
    , Vesterhus, M.
    N.
    , Folseraas, T.
    , Turgeon, C.
    T.
    , Ali, A.
    H.
    , Schlicht, E.
    M.
    , Atkinson, E.
    J.
    , Hu, C.
    , et al.
    (2021).
    Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation.
    Hepatology 74, 281-295.
    10.
    1002/hep.
    31652

    4.
    Sorrentino, G.
    , Perino, A.
    , Yildiz, E.
    , El Alam, G.
    , Bou Sleiman, M.
    , Gioiello, A.
    , Pellicciari, R.
    , and Schoonjans, K.
    (2020).
    Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration.
    Gastroenterology 159, 956-968 e958.
    10.
    1053/j.
    gastro.
    2020.
    05.
    067

    5.
    Jia, W.
    , Wei, M.
    , Rajani, C.
    , and Zheng, X.
    (2021).
    Targeting the alternative bile acid synthetic pathway for metabolic diseases.
    Protein & cell 12, 411-425.
    10.
    1007/s13238-020-00804-9

    6.
    Bertaggia, E.
    , Jensen, K.
    K.
    , Castro-Perez, J.
    , Xu, Y.
    , Di Paolo, G.
    , Chan, R.
    B.
    , Wang, L.
    , and Haeusler, R.
    A.
    (2017).
    Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption.
    Am J Physiol Endocrinol Metab 313, E121-E133.
    10.
    1152/ajpendo.
    00409.
    2016

    7.
    Kaur, A.
    , Patankar, J.
    V.
    , de Haan, W.
    , Ruddle, P.
    , Wijesekara, N.
    , Groen, A.
    K.
    , Verchere, C.
    B.
    , Singaraja, R.
    R.
    , and Hayden, M.
    R.
    (2015).
    Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1.
    Diabetes 64, 1168-1179.
    10.
    2337/db14-0716

    8.
    Abrigo, J.
    , Gonzalez, F.
    , Aguirre, F.
    , Tacchi, F.
    , Gonzalez, A.
    , Meza, M.
    P.
    , Simon, F.
    , Cabrera, D.
    , Arrese, M.
    , Karpen, S.
    , et al.
    (2021).
    Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor.
    Journal of cellular physiology 236, 260-272.
    10.
    1002/jcp.
    29839

    9.
    Fujino, T.
    , Une, M.
    , Imanaka, T.
    , Inoue, K.
    , and Nishimaki-Mogami, T.
    (2004).
    Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation.
    Journal of lipid research 45, 132-138.
    10.
    1194/jlr.
    M300215-JLR200

    Reprint Notice

    【Non-original article】The copyright of this article belongs to the author of the article, welcome to forward and share, without the permission of the author is prohibited from reprinting, the author has all legal rights, violators will be investigated
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.